Why Real-Time Intelligence Is Replacing Static Dashboards in Medical Affairs
For years, dashboards have been the standard way Medical Affairs teams monitor expert activity, scientific conversations, and engagement performance. They […]
Why Experts Don’t Fit Neatly Into Lists Anymore
For years, expert engagement started the same way: a list. Titles, publication counts, regions, and/or seniority. Once finalized, the list
Why Sentiment Tags Are the Missing Layer in Speaker Selection
Speaker selection has traditionally followed a familiar pattern: identify well-known experts, validate credentials, and build programs around visibility and reputation.
Beyond the Usual Names: Why Local Influence Deserves a Closer Look
When teams talk about expert engagement, the same names often surface first. Well-known global KOLs. High publication counts. Frequent conference
360-Degree Mapping for a 360-Degree Message: How Neolytica Aligns Strategy Across Medical and Commercial Teams
Medical and commercial teams rarely disagree on objectives. Both want relevant conversations, credible science, and measurable impact. Yet in practice,
From Strategy to Suggestion: How Ti Expert Makes Expert Engagement Measurable
Field and medical teams spend countless hours planning who to meet, what to discuss, and how to advance scientific conversations.
Next Best Dialogue: Moving from Generic to Personalized Communications in KOL Engagement
In medical affairs and field engagement, timing and context often decide the quality of every conversation. You can have the
Why Digital Sentiment Should Guide Your Scientific Engagement
Scientific engagement works best when it’s synchronized with how HCPs are thinking and talking today, not last quarter. That’s why
KEE Targeting 3.0: Beyond Lists, Beyond Channels, Beyond Assumptions
KEE targeting has evolved. Version 1.0 was spreadsheets of “top names.” Version 2.0 chased digital activity, who posts, where, and
Advanced Segmentation: From Role to Impact in KEE Targeting
Not all influence looks the same. Some experts write guidelines, others steer trial sites, and a growing cohort shapes thinking
